FIELD: immunology.
SUBSTANCE: the innovation deals with new immunogenic conjugates of beta-propionamide-bound polysaccharide and N-propionamide-bound oligosaccharide with protein, and the method to obtain these conjugates has been suggested, as well. Conjugates should be applied to obtain vaccines against infectious diseases and cancer that enables to broaden the number of preparations applied in treating the above-mentioned diseases.
EFFECT: higher efficiency.
1 dwg, 2 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| C-POLYSACCHARIDE-FREE CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE WITH A 2,5-ANHYDROMANOSE RESIDUE AT THE REDUCING END | 2023 |
|
RU2818894C1 |
| MOLECULE CONTAINING spr0096 AND spr2021 | 2012 |
|
RU2636350C2 |
| POLYSACCHARIDE FROM NEISSERIA MENINGITIDES CONTAINING MODIFIED GROUP B, CONJUGATED ANTIGEN, VACCINE AGAINST MENINGITIS GROUP B AND A METHOD OF INDUCTION OF ANTIBODY RESPONSE TO MENINGITIS OF GROUP B | 1990 |
|
RU2105568C1 |
| IMMUNOGENIC FUSED PROTEIN | 2016 |
|
RU2757426C2 |
| IMMUNOGENIC COMPOSITIONS | 2011 |
|
RU2608905C2 |
| METHOD OF PRODUCING CONJUGATE OF NONA-β-(1→3)-GLUCOSIDE WITH BOVINE SERUM ALBUMIN USING SQUARATE TECHNIQUE | 2011 |
|
RU2476444C1 |
| IMMUNOGENIC POLYSACCHARIDE-PROTEIN CONJUGATES CONTAINING A POLYSACCHARIDE DERIVED FROM GROUP B STREPTOCOCCUS | 2017 |
|
RU2791468C2 |
| CONJUGATES OF STREPTOCOCCUS POLYSACCHARIDE GROUP B AND PROTEIN, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATES, AND THEIR USE | 2016 |
|
RU2692923C2 |
| FUSED PROTEIN CAPABLE OF INDUCING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS AND VACCINE CONTAINING SAID PROTEIN | 2008 |
|
RU2487890C2 |
| COMBINED BACTERIAL MENINGITIS VACCINES TO BE INTRODUCED THROUGH MUCOUS MEMBRANE | 2003 |
|
RU2378008C2 |
